Skip to content
Screener

Insmed INSM Finance Lease Interest

Finance Lease Interest at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$1.43M-77.4%
RB Global logo
RB GlobalRBA
$1.4M+75.0%
Xylem logo
XylemXYL
$1.5M+50.0%
Insmed logo
InsmedINSM
$464K-11.5%
Kimberly-Clark logo
Kimberly-ClarkKMB
$750K0.0%
Vulcan Materials Company logo
Vulcan Materials CompanyVMC
$100K-50.0%

Other financials

Income statement

See full
Revenue$425.5M+296%
Gross profit$358.3M+352%
Operating income-$1.5M+99.5%
Net income-$13.2M+95.9%
EPS (diluted)-$0.06+96.5%

Balance sheet

See full
Cash & equivalents$544.8M-57.6%
Total debt$579.9M+0.8%
Total equity$757.5M-39.4%
Total assets$2.1B-15.2%

Cash flow

See full
Operating cash flow-$88.8M+56.8%
CapEx$6.3M+79.6%
Free cash flow-$95.1M+54.5%

Valuation

See full
Market cap$28.95B+37.0%
Enterprise value$28.98B+41.9%
P/S25.4×-27.6×

Profitability

See full
Gross margin83.5%+7.7pp
Operating margin-73.9%-30.6pp
Net margin-76.9%-31.8pp
FCF margin-71%-28.6pp

Returns & leverage

See full
Return on equity-87.2%-27.3pp
Debt / equity0.8×+0.3×
Current ratio3.7×-3.0×